Report Detail

Pharma & Healthcare Global Cognitive Decline Market Growth (Status and Outlook) 2022-2028

  • RnM4439193
  • |
  • 12 May, 2022
  • |
  • Global
  • |
  • 120 Pages
  • |
  • LPI(LP Information)
  • |
  • Pharma & Healthcare

1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Cognitive Decline Market Size 2017-2028
    • 2.1.2 Cognitive Decline Market Size CAGR by Region 2017 VS 2022 VS 2028
  • 2.2 Cognitive Decline Segment by Type
    • 2.2.1 Cholinesterase Inhibitors
    • 2.2.2 NMDA receptor antagonists
  • 2.3 Cognitive Decline Market Size by Type
    • 2.3.1 Cognitive Decline Market Size CAGR by Type (2017 VS 2022 VS 2028)
    • 2.3.2 Global Cognitive Decline Market Size Market Share by Type (2017-2022)
  • 2.4 Cognitive Decline Segment by Application
    • 2.4.1 Mild Cognitive Impairment (MCI)
    • 2.4.2 Dementia
  • 2.5 Cognitive Decline Market Size by Application
    • 2.5.1 Cognitive Decline Market Size CAGR by Application (2017 VS 2022 VS 2028)
    • 2.5.2 Global Cognitive Decline Market Size Market Share by Application (2017-2022)

3 Cognitive Decline Market Size by Player

  • 3.1 Cognitive Decline Market Size Market Share by Players
    • 3.1.1 Global Cognitive Decline Revenue by Players (2020-2022)
    • 3.1.2 Global Cognitive Decline Revenue Market Share by Players (2020-2022)
  • 3.2 Global Cognitive Decline Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 Cognitive Decline by Regions

  • 4.1 Cognitive Decline Market Size by Regions (2017-2022)
  • 4.2 Americas Cognitive Decline Market Size Growth (2017-2022)
  • 4.3 APAC Cognitive Decline Market Size Growth (2017-2022)
  • 4.4 Europe Cognitive Decline Market Size Growth (2017-2022)
  • 4.5 Middle East & Africa Cognitive Decline Market Size Growth (2017-2022)

5 Americas

  • 5.1 Americas Cognitive Decline Market Size by Country (2017-2022)
  • 5.2 Americas Cognitive Decline Market Size by Type (2017-2022)
  • 5.3 Americas Cognitive Decline Market Size by Application (2017-2022)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Cognitive Decline Market Size by Region (2017-2022)
  • 6.2 APAC Cognitive Decline Market Size by Type (2017-2022)
  • 6.3 APAC Cognitive Decline Market Size by Application (2017-2022)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe Cognitive Decline by Country (2017-2022)
  • 7.2 Europe Cognitive Decline Market Size by Type (2017-2022)
  • 7.3 Europe Cognitive Decline Market Size by Application (2017-2022)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Cognitive Decline by Region (2017-2022)
  • 8.2 Middle East & Africa Cognitive Decline Market Size by Type (2017-2022)
  • 8.3 Middle East & Africa Cognitive Decline Market Size by Application (2017-2022)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Global Cognitive Decline Market Forecast

  • 10.1 Global Cognitive Decline Forecast by Regions (2023-2028)
    • 10.1.1 Global Cognitive Decline Forecast by Regions (2023-2028)
    • 10.1.2 Americas Cognitive Decline Forecast
    • 10.1.3 APAC Cognitive Decline Forecast
    • 10.1.4 Europe Cognitive Decline Forecast
    • 10.1.5 Middle East & Africa Cognitive Decline Forecast
  • 10.2 Americas Cognitive Decline Forecast by Country (2023-2028)
    • 10.2.1 United States Cognitive Decline Market Forecast
    • 10.2.2 Canada Cognitive Decline Market Forecast
    • 10.2.3 Mexico Cognitive Decline Market Forecast
    • 10.2.4 Brazil Cognitive Decline Market Forecast
  • 10.3 APAC Cognitive Decline Forecast by Region (2023-2028)
    • 10.3.1 China Cognitive Decline Market Forecast
    • 10.3.2 Japan Cognitive Decline Market Forecast
    • 10.3.3 Korea Cognitive Decline Market Forecast
    • 10.3.4 Southeast Asia Cognitive Decline Market Forecast
    • 10.3.5 India Cognitive Decline Market Forecast
    • 10.3.6 Australia Cognitive Decline Market Forecast
  • 10.4 Europe Cognitive Decline Forecast by Country (2023-2028)
    • 10.4.1 Germany Cognitive Decline Market Forecast
    • 10.4.2 France Cognitive Decline Market Forecast
    • 10.4.3 UK Cognitive Decline Market Forecast
    • 10.4.4 Italy Cognitive Decline Market Forecast
    • 10.4.5 Russia Cognitive Decline Market Forecast
  • 10.5 Middle East & Africa Cognitive Decline Forecast by Region (2023-2028)
    • 10.5.1 Egypt Cognitive Decline Market Forecast
    • 10.5.2 South Africa Cognitive Decline Market Forecast
    • 10.5.3 Israel Cognitive Decline Market Forecast
    • 10.5.4 Turkey Cognitive Decline Market Forecast
    • 10.5.5 GCC Countries Cognitive Decline Market Forecast
  • 10.6 Global Cognitive Decline Forecast by Type (2023-2028)
  • 10.7 Global Cognitive Decline Forecast by Application (2023-2028)

11 Key Players Analysis

  • 11.1 Stryker
    • 11.1.1 Stryker Company Information
    • 11.1.2 Stryker Cognitive Decline Product Offered
    • 11.1.3 Stryker Cognitive Decline Revenue, Gross Margin and Market Share (2020-2022)
    • 11.1.4 Stryker Main Business Overview
    • 11.1.5 Stryker Latest Developments
  • 11.2 Smith & Nephew
    • 11.2.1 Smith & Nephew Company Information
    • 11.2.2 Smith & Nephew Cognitive Decline Product Offered
    • 11.2.3 Smith & Nephew Cognitive Decline Revenue, Gross Margin and Market Share (2020-2022)
    • 11.2.4 Smith & Nephew Main Business Overview
    • 11.2.5 Smith & Nephew Latest Developments
  • 11.3 Hill-Rom Services Inc.
    • 11.3.1 Hill-Rom Services Inc. Company Information
    • 11.3.2 Hill-Rom Services Inc. Cognitive Decline Product Offered
    • 11.3.3 Hill-Rom Services Inc. Cognitive Decline Revenue, Gross Margin and Market Share (2020-2022)
    • 11.3.4 Hill-Rom Services Inc. Main Business Overview
    • 11.3.5 Hill-Rom Services Inc. Latest Developments
  • 11.4 Paramount Bed Holdings Co., Ltd.
    • 11.4.1 Paramount Bed Holdings Co., Ltd. Company Information
    • 11.4.2 Paramount Bed Holdings Co., Ltd. Cognitive Decline Product Offered
    • 11.4.3 Paramount Bed Holdings Co., Ltd. Cognitive Decline Revenue, Gross Margin and Market Share (2020-2022)
    • 11.4.4 Paramount Bed Holdings Co., Ltd. Main Business Overview
    • 11.4.5 Paramount Bed Holdings Co., Ltd. Latest Developments
  • 11.5 ArjoHuntleigh
    • 11.5.1 ArjoHuntleigh Company Information
    • 11.5.2 ArjoHuntleigh Cognitive Decline Product Offered
    • 11.5.3 ArjoHuntleigh Cognitive Decline Revenue, Gross Margin and Market Share (2020-2022)
    • 11.5.4 ArjoHuntleigh Main Business Overview
    • 11.5.5 ArjoHuntleigh Latest Developments
  • 11.6 Talley Group Limited
    • 11.6.1 Talley Group Limited Company Information
    • 11.6.2 Talley Group Limited Cognitive Decline Product Offered
    • 11.6.3 Talley Group Limited Cognitive Decline Revenue, Gross Margin and Market Share (2020-2022)
    • 11.6.4 Talley Group Limited Main Business Overview
    • 11.6.5 Talley Group Limited Latest Developments
  • 11.7 Drive DeVilbiss Healthcare Ltd (Sidhil Limited)
    • 11.7.1 Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Company Information
    • 11.7.2 Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Cognitive Decline Product Offered
    • 11.7.3 Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Cognitive Decline Revenue, Gross Margin and Market Share (2020-2022)
    • 11.7.4 Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Main Business Overview
    • 11.7.5 Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Latest Developments
  • 11.8 Apex Medical Corp.
    • 11.8.1 Apex Medical Corp. Company Information
    • 11.8.2 Apex Medical Corp. Cognitive Decline Product Offered
    • 11.8.3 Apex Medical Corp. Cognitive Decline Revenue, Gross Margin and Market Share (2020-2022)
    • 11.8.4 Apex Medical Corp. Main Business Overview
    • 11.8.5 Apex Medical Corp. Latest Developments
  • 11.9 Medtronic
    • 11.9.1 Medtronic Company Information
    • 11.9.2 Medtronic Cognitive Decline Product Offered
    • 11.9.3 Medtronic Cognitive Decline Revenue, Gross Margin and Market Share (2020-2022)
    • 11.9.4 Medtronic Main Business Overview
    • 11.9.5 Medtronic Latest Developments
  • 11.10 PROMA REHA, s. r. o.
    • 11.10.1 PROMA REHA, s. r. o. Company Information
    • 11.10.2 PROMA REHA, s. r. o. Cognitive Decline Product Offered
    • 11.10.3 PROMA REHA, s. r. o. Cognitive Decline Revenue, Gross Margin and Market Share (2020-2022)
    • 11.10.4 PROMA REHA, s. r. o. Main Business Overview
    • 11.10.5 PROMA REHA, s. r. o. Latest Developments
  • 11.11 Linet spol. S R.O.
    • 11.11.1 Linet spol. S R.O. Company Information
    • 11.11.2 Linet spol. S R.O. Cognitive Decline Product Offered
    • 11.11.3 Linet spol. S R.O. Cognitive Decline Revenue, Gross Margin and Market Share (2020-2022)
    • 11.11.4 Linet spol. S R.O. Main Business Overview
    • 11.11.5 Linet spol. S R.O. Latest Developments
  • 11.12 DARCO International
    • 11.12.1 DARCO International Company Information
    • 11.12.2 DARCO International Cognitive Decline Product Offered
    • 11.12.3 DARCO International Cognitive Decline Revenue, Gross Margin and Market Share (2020-2022)
    • 11.12.4 DARCO International Main Business Overview
    • 11.12.5 DARCO International Latest Developments
  • 11.13 DeRoyal Industries
    • 11.13.1 DeRoyal Industries Company Information
    • 11.13.2 DeRoyal Industries Cognitive Decline Product Offered
    • 11.13.3 DeRoyal Industries Cognitive Decline Revenue, Gross Margin and Market Share (2020-2022)
    • 11.13.4 DeRoyal Industries Main Business Overview
    • 11.13.5 DeRoyal Industries Latest Developments
  • 11.14 BSN Medical (Essity)
    • 11.14.1 BSN Medical (Essity) Company Information
    • 11.14.2 BSN Medical (Essity) Cognitive Decline Product Offered
    • 11.14.3 BSN Medical (Essity) Cognitive Decline Revenue, Gross Margin and Market Share (2020-2022)
    • 11.14.4 BSN Medical (Essity) Main Business Overview
    • 11.14.5 BSN Medical (Essity) Latest Developments
  • 11.15 Mölnlycke Health Care
    • 11.15.1 Mölnlycke Health Care Company Information
    • 11.15.2 Mölnlycke Health Care Cognitive Decline Product Offered
    • 11.15.3 Mölnlycke Health Care Cognitive Decline Revenue, Gross Margin and Market Share (2020-2022)
    • 11.15.4 Mölnlycke Health Care Main Business Overview
    • 11.15.5 Mölnlycke Health Care Latest Developments
  • 11.16 TrueKAST (Wound Kair Concepts)
    • 11.16.1 TrueKAST (Wound Kair Concepts) Company Information
    • 11.16.2 TrueKAST (Wound Kair Concepts) Cognitive Decline Product Offered
    • 11.16.3 TrueKAST (Wound Kair Concepts) Cognitive Decline Revenue, Gross Margin and Market Share (2020-2022)
    • 11.16.4 TrueKAST (Wound Kair Concepts) Main Business Overview
    • 11.16.5 TrueKAST (Wound Kair Concepts) Latest Developments
  • 11.17 Thuasne SAS
    • 11.17.1 Thuasne SAS Company Information
    • 11.17.2 Thuasne SAS Cognitive Decline Product Offered
    • 11.17.3 Thuasne SAS Cognitive Decline Revenue, Gross Margin and Market Share (2020-2022)
    • 11.17.4 Thuasne SAS Main Business Overview
    • 11.17.5 Thuasne SAS Latest Developments
  • 11.18 DJO Global
    • 11.18.1 DJO Global Company Information
    • 11.18.2 DJO Global Cognitive Decline Product Offered
    • 11.18.3 DJO Global Cognitive Decline Revenue, Gross Margin and Market Share (2020-2022)
    • 11.18.4 DJO Global Main Business Overview
    • 11.18.5 DJO Global Latest Developments
  • 11.19 ORTHOSERVICE AG
    • 11.19.1 ORTHOSERVICE AG Company Information
    • 11.19.2 ORTHOSERVICE AG Cognitive Decline Product Offered
    • 11.19.3 ORTHOSERVICE AG Cognitive Decline Revenue, Gross Margin and Market Share (2020-2022)
    • 11.19.4 ORTHOSERVICE AG Main Business Overview
    • 11.19.5 ORTHOSERVICE AG Latest Developments
  • 11.20 Breg, Inc.
    • 11.20.1 Breg, Inc. Company Information
    • 11.20.2 Breg, Inc. Cognitive Decline Product Offered
    • 11.20.3 Breg, Inc. Cognitive Decline Revenue, Gross Margin and Market Share (2020-2022)
    • 11.20.4 Breg, Inc. Main Business Overview
    • 11.20.5 Breg, Inc. Latest Developments
  • 11.21 Advanced Orthopaedics
    • 11.21.1 Advanced Orthopaedics Company Information
    • 11.21.2 Advanced Orthopaedics Cognitive Decline Product Offered
    • 11.21.3 Advanced Orthopaedics Cognitive Decline Revenue, Gross Margin and Market Share (2020-2022)
    • 11.21.4 Advanced Orthopaedics Main Business Overview
    • 11.21.5 Advanced Orthopaedics Latest Developments
  • 11.22 ALGEOS
    • 11.22.1 ALGEOS Company Information
    • 11.22.2 ALGEOS Cognitive Decline Product Offered
    • 11.22.3 ALGEOS Cognitive Decline Revenue, Gross Margin and Market Share (2020-2022)
    • 11.22.4 ALGEOS Main Business Overview
    • 11.22.5 ALGEOS Latest Developments
  • 11.23 Hollister Incorporated
    • 11.23.1 Hollister Incorporated Company Information
    • 11.23.2 Hollister Incorporated Cognitive Decline Product Offered
    • 11.23.3 Hollister Incorporated Cognitive Decline Revenue, Gross Margin and Market Share (2020-2022)
    • 11.23.4 Hollister Incorporated Main Business Overview
    • 11.23.5 Hollister Incorporated Latest Developments
  • 11.24 ConvaTec Group plc
    • 11.24.1 ConvaTec Group plc Company Information
    • 11.24.2 ConvaTec Group plc Cognitive Decline Product Offered
    • 11.24.3 ConvaTec Group plc Cognitive Decline Revenue, Gross Margin and Market Share (2020-2022)
    • 11.24.4 ConvaTec Group plc Main Business Overview
    • 11.24.5 ConvaTec Group plc Latest Developments
  • 11.25 Coloplast A/S
    • 11.25.1 Coloplast A/S Company Information
    • 11.25.2 Coloplast A/S Cognitive Decline Product Offered
    • 11.25.3 Coloplast A/S Cognitive Decline Revenue, Gross Margin and Market Share (2020-2022)
    • 11.25.4 Coloplast A/S Main Business Overview
    • 11.25.5 Coloplast A/S Latest Developments
  • 11.26 Medline Industries Inc.
    • 11.26.1 Medline Industries Inc. Company Information
    • 11.26.2 Medline Industries Inc. Cognitive Decline Product Offered
    • 11.26.3 Medline Industries Inc. Cognitive Decline Revenue, Gross Margin and Market Share (2020-2022)
    • 11.26.4 Medline Industries Inc. Main Business Overview
    • 11.26.5 Medline Industries Inc. Latest Developments
  • 11.27 Invacare Corporation
    • 11.27.1 Invacare Corporation Company Information
    • 11.27.2 Invacare Corporation Cognitive Decline Product Offered
    • 11.27.3 Invacare Corporation Cognitive Decline Revenue, Gross Margin and Market Share (2020-2022)
    • 11.27.4 Invacare Corporation Main Business Overview
    • 11.27.5 Invacare Corporation Latest Developments

12 Research Findings and Conclusion

As the global economy mends, the 2021 growth of Cognitive Decline will have significant change from previous year. According to our (LP Information) latest study, the global Cognitive Decline market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Cognitive Decline market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.

The United States Cognitive Decline market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Cognitive Decline market, reaching US$ million by the year 2028. As for the Europe Cognitive Decline landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Cognitive Decline players cover Stryker, Smith & Nephew, Hill-Rom Services Inc., and Paramount Bed Holdings Co., Ltd., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Cognitive Decline market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
by Drug Therapy
Cholinesterase Inhibitors
NMDA receptor antagonists
by Non-Invasive Stimulation Devices
Vagus Nerve Stimulators
Deep Brain Stimulators
Transcranial Magnetic Stimulators (TMSs)

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Mild Cognitive Impairment (MCI)
Dementia

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Stryker
Smith & Nephew
Hill-Rom Services Inc.
Paramount Bed Holdings Co., Ltd.
ArjoHuntleigh
Talley Group Limited
Drive DeVilbiss Healthcare Ltd (Sidhil Limited)
Apex Medical Corp.
Medtronic
PROMA REHA, s. r. o.
Linet spol. S R.O.
DARCO International
DeRoyal Industries
BSN Medical (Essity)
Mölnlycke Health Care
TrueKAST (Wound Kair Concepts)
Thuasne SAS
DJO Global
ORTHOSERVICE AG
Breg, Inc.
Advanced Orthopaedics
ALGEOS
Hollister Incorporated
ConvaTec Group plc
Coloplast A/S
Medline Industries Inc.
Invacare Corporation


Summary:
Get latest Market Research Reports on Cognitive Decline. Industry analysis & Market Report on Cognitive Decline is a syndicated market report, published as Global Cognitive Decline Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Cognitive Decline market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,650.00
$7,320.00
2,923.65
5,863.32
3,456.55
6,932.04
467,528.50
937,618.80
284,298.50
570,154.80
Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report